相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Acute and chronic ethanol differentially modify the emotional significance of a novel environment: implications for addiction
Daniela F. Fukushiro et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Effect of Aripiprazole on Anxiety Associated With Ethanol Physical Dependence and on Ethanol-Induced Place Preference
Masahiro Shibasaki et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2012)
Extent of illicit drug use and dependence, and their contribution to the global burden of disease
Louisa Degenhardt et al.
LANCET (2012)
Anti-aversive effects of the atypical antipsychotic, aripiprazole, in animal models of anxiety
Caroline Biojone et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Aripiprazole: A Drug with a Novel Mechanism of Action and Possible Efficacy for Alcohol Dependence
Derick E. Vergne et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
Pharmacotherapies for Alcoholism: The Old and the New
M. Foster Olive
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
Identification of Molecular Targets Associated with Ethanol Toxicity and Implications in Drug Development
Lin-Lin Wang et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Environmental novelty and illumination modify ethanol-induced open-field behavioral effects in mice
Daniela F. Fukushiro et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
A safety and tolerability laboratory study of the combination of aripiprazole and topiramate in volunteers who drink alcohol
George A. Kenna et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2009)
Mice with Altered Myelin Proteolipid Protein Gene Expression Display Cognitive Deficits Accompanied by Abnormal Neuron-Glia Interactions and Decreased Conduction Velocities
Hisataka Tanaka et al.
JOURNAL OF NEUROSCIENCE (2009)
Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse
Matthew W. Feltenstein et al.
PSYCHOPHARMACOLOGY (2009)
The antipsychotic aripiprazole antagonizes the ethanol- and amphetamine-induced locomotor stimulation in mice
Elisabet Jerlhag
ALCOHOL (2008)
Changes in Alcohol-Related Mortality and its Socioeconomic Differences After a Large Reduction in Alcohol Prices: A Natural Experiment Based on Register Data
Kimmo Herttua et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Neuropharmacology of alcohol addiction
V. Vengeliene et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Aripiprazole, an atypical antipsychotic prevents the motor hyperactivity induced by psychotomimetics, and psyphostimulants in mice
Juliana V. Leite et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Current evidence for aripiprazole as augmentation therapy in major depressive disorder
Arif Khan
Expert Review of Neurotherapeutics (2008)
A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence
Raymond F. Anton et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Behavioral phenotyping strategies for mutant mice
Jacqueline N. Crawley
NEURON (2008)
Evidence-based treatments of addiction
Charles P. O'Brien
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2008)
Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats
Morgane Thomsen et al.
PSYCHOPHARMACOLOGY (2008)
Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice
Gunnar Sorensen et al.
PSYCHOPHARMACOLOGY (2008)
Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT2A receptors:: functional receptor-binding and in vivo electrophysiological studies
Arlene D. Stark et al.
PSYCHOPHARMACOLOGY (2007)
Effects of aripiprazole on alcohol intake in an animal model of high-alcohol drinking
Kimmo Ingman et al.
ALCOHOL AND ALCOHOLISM (2006)
Drug-induced home cage conspecifics' behavior can potentiate behavioral sensitization in mice
N. P. Araujo et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2006)
A hitchhiker's guide to behavioral analysis in laboratory rodents
N Sousa et al.
GENES BRAIN AND BEHAVIOR (2006)
Laboratory models of alcoholism: treatment target identification and insight into mechanisms
DM Lovinger et al.
NATURE NEUROSCIENCE (2005)
The importance of housing conditions on behavioral sensitization and tolerance to ethanol
NP Araujo et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
The place of partial agonism in psychiatry: recent developments
RI Ohlsen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2005)
Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice
FA Moreira et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Unhealthy alcohol use
R Saitz
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile
T Hirose et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2004)
Alcohol addiction research: from animal models to clinics
R Spanagel
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2003)
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology
DA Shapiro et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone
S Nakai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials.
SR Marder et al.
SCHIZOPHRENIA RESEARCH (2003)
Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder
JM Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors
KD Burris et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor
S Jordan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis
C. A. Tamminga et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2002)